Rohnert Park, CA, United States of America

Osman Güner

This inventor holds 1 USPTO granted patent. Top assignees: Emory University, Howard University, Mercer University. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I focus on the sphere of innovations, inventions, inventors, patent attorneys, assignees, and patents. Thus, I'll provide you with the requested article about inventor Osman Güner.

Title: Exploring the Innovations of Osman Güner - A Pioneer in NADPH Oxidase Inhibitors

Introduction:

Osman Güner is a renowned inventor based in Rohnert Park, CA (US) known for his groundbreaking work in the development of NADPH oxidase inhibitors and their applications in treating various diseases and conditions. With a patent portfolio that showcases his expertise, Güner has made significant contributions to the field of pharmaceuticals.

Latest Patents:

Güner's notable patent, titled "NADPH oxidase inhibitors and uses thereof," focuses on compounds and methods for treating or preventing Nox-related diseases by administering Nox inhibitors or pharmaceutical compositions comprising these inhibitors. The patent emphasizes the use of sulfonylurea compounds for the reported purposes.

Career Highlights:

Having accumulated a total of 1 patent, Güner has demonstrated his proficiency in developing innovative solutions for complex medical challenges. His work reflects a dedication to advancing the pharmaceutical industry through cutting-edge research and novel therapeutic approaches.

Collaborations:

Throughout his career, Güner has collaborated with esteemed institutions such as Emory University and Mercer University. Working alongside notable colleagues like Bernard Lassegue and Kathy Griendling, Güner has fostered a collaborative environment conducive to innovation and breakthrough discoveries.

Conclusion:

In conclusion, Osman Güner stands out as a pioneering inventor in the realm of NADPH oxidase inhibitors, with a patent portfolio that highlights his exceptional contributions to the field. Through his collaborations and career accomplishments, Güner has solidified his reputation as a trailblazer in pharmaceutical innovation, shaping the future of healthcare with his groundbreaking inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…